CSwMR

Table 3.26 Availability of essential medicines and commodities for chronic respiratory diseases
Among facilities offering services for chronic respiratory diseases, the percentages having the indicated essential medicines and commodities
observed at the service site on the day of the survey by background characteristics, Senegal SCSPA 2012–2013
Background
characteristics
Salbutamol
inhaler
Percentage of facilities offering services for chronic
respiratory diseases that have the indicated medicines and commodities
Beclomethasone
inhaler
Prednisolone
tablets
Hydrocortisone
tablets
Injectable
epinephrine Oxygen 1
Number of
facilities offering
services for
chronic
respiratory
diseases
Facility type
Hospital 40 12 6 65 21 67 15
Health center 41 0 3 73 5 23 29
Health post 21 0 2 54 1 3 302
Managing authority
Public 22 0 2 58 2 5 291
Private 32 4 8 42 6 19 54
Region
Dakar 20 1 1 26 3 15 60
Diourbel 0 0 0 49 2 8 25
Fatick 2 0 0 61 0 4 22
Kaffrine 72 0 0 100 0 4 14
Kaolack 2 0 0 47 0 11 23
Kédougou 39 5 5 75 0 22 9
Kolda 45 0 12 67 12 3 16
Louga 20 0 0 78 0 0 23
Matam 1 6 0 65 1 1 17
Saint Louis 4 0 0 59 0 4 27
Sédhiou 57 0 8 58 8 3 12
Tambacounda 18 0 0 53 0 4 23
Thiès 23 3 6 63 7 9 47
Ziguinchor 73 0 10 56 0 0 29
Total 24 1 3 56 2 7 345
Note: The indicators presented in this table comprise the medicines and commodities domain for assessing readiness to provide services for
chronic respiratory diseases within the health facility assessment methodology proposed by WHO and USAID (2012).
1
In cylinders or concentrators or an oxygen distribution system.
3.11 Tuberculosis
The SCSPA 2012-2013 was used to assess the percentage of facilities having the
capacity to diagnose tuberculosis (TB) and having the drugs available for treatment.
Table 3.27 presents the diagnostic capacity and the availability of drugs for the
treatment of TB in facilities providing services for the diagnosis and/or treatment of TB.
Diagnosis
Among facilities offering services for the diagnosis and/or treatment of TB, 15
percent have the capacity to diagnosis TB by smear microscopy. Diagnosis by microscopy is
performed in hospitals (72 percent) and health centers (71 percent) but in only 3 percent of
health posts.
Among facilities offering services for the diagnosis and/or treatment of TB, 88
percent can also diagnose HIV. In 9 of the 14 regions in Senegal, all facilities providing
services for the diagnosis and/or treatment of TB have the capacity to diagnose HIV. For the
other regions, more than two-thirds of these facilities have this diagnostic capacity. This
diagnostic capability is much more common in public facilities (94 percent) than private (56
percent). Almost all hospitals, health centers and health posts have the capacity to make this
diagnosis.
46